Candice Internicola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Candice Internicola has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Olivier Peyruchaud
Faculté de Médecine Lyon Est-Domaine Laennec, Université Lyon 1, 69372 Lyon, France
2 shared publications - Andrew A. McCarthy
European Molecular Biology Laboratory (EMBL), Grenoble, France
1 shared publication Anne Briolay
1 shared publication- Carole Bougault
Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, Université de Lyon, Université Lyon 1, UMR CNRS 5246, 69 622 Villeurbanne Cedex, France
1 shared publication Cinthia-Nayeli Cuero
Universite Claude Bernard Lyon 1, INSERM, UMR 1033, LYOS, Lyon, France
1 shared publication- David Cheillan
Service Biochimie et Biologie Moléculaire, Groupement Hospitalier Est, Hospices Civils de Lyon, 69002 Lyon, France
1 shared publication
Latest Publications
- Open Access
- 7 November 2026
- Published by Elsevier in Bone Reports
- Vol. 31
Spondyloarthritis-like peripheral bone and entheseal lesions in TgA86 mice: Sphingolipid metabolism dysregulation and sex-related differences
- 7 November 2026
- Published by Elsevier in Bone Reports
- Vol. 31
Open AccessSpondyloarthritis-like peripheral bone and entheseal lesions in TgA86 mice: Sphingolipid metabolism dysregulation and sex-related differences
- Open Access
Lysophosphatidic acid controls autotaxin binding to β1-integrin : impact on disease progression in murine collagen-induced arthritis
Autotaxin (ATX) is a lysophospholipase D (lysoPLD) serving as both a lysophosphatidic acid (LPA)-producing enzyme and a LPA docking molecule. ATX binds to the cell surface via interaction with adhesive molecules, including β1-integrin, potentially facilitating LPA access to its specific G protein-coupled receptors. However, the precise protein-protein interaction sequences and their biological implications remain unknown. Here, we identify the interaction domains between ATX and β1-integrin and generate specific blocking antibodies allowing to demonstrate that ATX-β1 binding domain involves a cryptic epitope unmasked by LPA docking. In addition, whereas anti-ATX antibodies do not inhibit the lysoPLD activity, immunological neutralization of the ATX-β1 integrin binding site reduces arthritis development in a collagen-induced arthritis model. These findings offer novel insights into the molecular mechanisms governing ATX functions, which, in addition to its enzymatic activity, requires cell surface binding. These findings suggest that ATX binding domains could be targeted for novel therapeutic approaches.
Open AccessLysophosphatidic acid controls autotaxin binding to β1-integrin : impact on disease progression in murine collagen-induced arthritis
Autotaxin (ATX) is a lysophospholipase D (lysoPLD) serving as both a lysophosphatidic acid (LPA)-producing enzyme and a LPA docking molecule. ATX binds to the cell surface via interaction with adhesive molecules, including β1-integrin, potentially facilitating LPA access to its specific G protein-coupled receptors. However, the precise protein-protein interaction sequences and their biological implications remain unknown. Here, we identify the interaction domains between ATX and β1-integrin and generate specific blocking antibodies allowing to demonstrate that ATX-β1 binding domain involves a cryptic epitope unmasked by LPA docking. In addition, whereas anti-ATX antibodies do not inhibit the lysoPLD activity, immunological neutralization of the ATX-β1 integrin binding site reduces arthritis development in a collagen-induced arthritis model. These findings offer novel insights into the molecular mechanisms governing ATX functions, which, in addition to its enzymatic activity, requires cell surface binding. These findings suggest that ATX binding domains could be targeted for novel therapeutic approaches.